BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bottani E, Lamperti C, Prigione A, Tiranti V, Persico N, Brunetti D. Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies. Pharmaceutics 2020;12:E1083. [PMID: 33187380 DOI: 10.3390/pharmaceutics12111083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Panda SP, Dhurandhar Y, Agrawal M. The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. Mitochondrion 2022;66:27-37. [PMID: 35842181 DOI: 10.1016/j.mito.2022.07.002] [Reference Citation Analysis]
2 Moos WH, Faller DV, Glavas IP, Harpp DN, Kamperi N, Kanara I, Kodukula K, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Tamvakopoulos C, Vavvas DG, Zamboni RJ, Chen X. Treatment and prevention of pathological mitochondrial dysfunction in retinal degeneration and in photoreceptor injury. Biochem Pharmacol 2022;203:115168. [PMID: 35835206 DOI: 10.1016/j.bcp.2022.115168] [Reference Citation Analysis]
3 Zhao J, Wang X, Huo Z, Chen Y, Liu J, Zhao Z, Meng F, Su Q, Bao W, Zhang L, Wen S, Wang X, Liu H, Zhou S. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis. Cells 2022;11:2049. [DOI: 10.3390/cells11132049] [Reference Citation Analysis]
4 Di Donfrancesco A, Massaro G, Di Meo I, Tiranti V, Bottani E, Brunetti D. Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective. Pharmaceutics 2022;14:1287. [PMID: 35745859 DOI: 10.3390/pharmaceutics14061287] [Reference Citation Analysis]
5 Aldossary AM, Tawfik EA, Alomary MN, Alsudir SA, Alfahad AJ, Alshehri AA, Almughem FA, Mohammed RY, Alzaydi MM. Recent Advances in Mitochondrial Diseases: from Molecular Insights to Therapeutic Perspectives. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.011] [Reference Citation Analysis]
6 Kopecka J. Mitochondria-Targeted Drug Delivery. Pharmaceutics 2022;14:178. [PMID: 35057073 DOI: 10.3390/pharmaceutics14010178] [Reference Citation Analysis]
7 Reiter RJ, Sharma R, Rosales-Corral S, Manucha W, Chuffa LGA, Zuccari DAPC. Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells. Int J Mol Sci 2021;22:12494. [PMID: 34830375 DOI: 10.3390/ijms222212494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 di Punzio G, Gilberti M, Baruffini E, Lodi T, Donnini C, Dallabona C. A Yeast-Based Repurposing Approach for the Treatment of Mitochondrial DNA Depletion Syndromes Led to the Identification of Molecules Able to Modulate the dNTP Pool. Int J Mol Sci 2021;22:12223. [PMID: 34830106 DOI: 10.3390/ijms222212223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fan HC, Lee HF, Yue CT, Chi CS. Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes. Life (Basel) 2021;11:1111. [PMID: 34832987 DOI: 10.3390/life11111111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Roberts FL, Markby GR. New Insights into Molecular Mechanisms Mediating Adaptation to Exercise; A Review Focusing on Mitochondrial Biogenesis, Mitochondrial Function, Mitophagy and Autophagy. Cells 2021;10:2639. [PMID: 34685618 DOI: 10.3390/cells10102639] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Habbane M, Montoya J, Rhouda T, Sbaoui Y, Radallah D, Emperador S. Human Mitochondrial DNA: Particularities and Diseases. Biomedicines 2021;9:1364. [PMID: 34680481 DOI: 10.3390/biomedicines9101364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lichtenstein M, Zabit S, Hauser N, Farouz S, Melloul O, Hirbawi J, Lorberboum-Galski H. TAT for Enzyme/Protein Delivery to Restore or Destroy Cell Activity in Human Diseases. Life (Basel) 2021;11:924. [PMID: 34575072 DOI: 10.3390/life11090924] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zanfardino P, Doccini S, Santorelli FM, Petruzzella V. Tackling Dysfunction of Mitochondrial Bioenergetics in the Brain. Int J Mol Sci 2021;22:8325. [PMID: 34361091 DOI: 10.3390/ijms22158325] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Tiet MY, Lin Z, Gao F, Jennings MJ, Horvath R. Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a 'Treatabolome'. J Neuromuscul Dis 2021. [PMID: 34308912 DOI: 10.3233/JND-210715] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Brunetti D, Catania A, Viscomi C, Deleidi M, Bindoff LA, Ghezzi D, Zeviani M. Role of PITRM1 in Mitochondrial Dysfunction and Neurodegeneration. Biomedicines 2021;9:833. [PMID: 34356897 DOI: 10.3390/biomedicines9070833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Dabravolski SA, Orekhova VA, Baig MS, Bezsonov EE, Starodubova AV, Popkova TV, Orekhov AN. The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes. Int J Mol Sci 2021;22:6733. [PMID: 34201756 DOI: 10.3390/ijms22136733] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
17 Rossmann MP, Dubois SM, Agarwal S, Zon LI. Mitochondrial function in development and disease. Dis Model Mech 2021;14:dmm048912. [PMID: 34114603 DOI: 10.1242/dmm.048912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rugolo M, Zanna C, Ghelli AM. Organization of the Respiratory Supercomplexes in Cells with Defective Complex III: Structural Features and Metabolic Consequences. Life (Basel) 2021;11:351. [PMID: 33920624 DOI: 10.3390/life11040351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Inak G, Rybak-Wolf A, Lisowski P, Pentimalli TM, Jüttner R, Glažar P, Uppal K, Bottani E, Brunetti D, Secker C, Zink A, Meierhofer D, Henke MT, Dey M, Ciptasari U, Mlody B, Hahn T, Berruezo-Llacuna M, Karaiskos N, Di Virgilio M, Mayr JA, Wortmann SB, Priller J, Gotthardt M, Jones DP, Mayatepek E, Stenzel W, Diecke S, Kühn R, Wanker EE, Rajewsky N, Schuelke M, Prigione A. Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome. Nat Commun 2021;12:1929. [PMID: 33771987 DOI: 10.1038/s41467-021-22117-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
20 Huang C, Bian J, Cao Q, Chen XM, Pollock CA. The Mitochondrial Kinase PINK1 in Diabetic Kidney Disease. Int J Mol Sci 2021;22:1525. [PMID: 33546409 DOI: 10.3390/ijms22041525] [Cited by in F6Publishing: 5] [Reference Citation Analysis]